PMID: 16629440Apr 25, 2006Paper

Active transport to work in Australia: is it all downhill from here?

Asia-Pacific Journal of Public Health
A C BellB A Swinburn

Abstract

Physical inactivity is increasing in Australia and active forms of transportation may be one way to increase the working population's daily physical activity. We used travel-to-work data from employed persons aged 15 years and over participating in the 1996 (n = 7,636,319) and 2001 (n = 8,298,606) Australian censuses to determine prevalence and trends in walking and cycling to work by state and gender, and differences in prevalence by age. In 2001, 3.8% of Australians walked to work and < 1% cycled. Over 64% travelled to work by car. There have been small declines in walking (men and women) and cycling (men) over the 5-years from 1996 to 2001. People were more likely to walk or cycle to work if they lived in the Northern Territory, if they were male or if they were aged 15 to 24 years. They were more likely to travel by car if they lived in the Australian Capital Territory, if they were male, or if they were aged 45-54 years. Few people walk or cycle to work in Australia. Efforts to encourage active transportation are urgently needed.

References

Nov 10, 1998·American Journal of Public Health·I H Yen, G A Kaplan
Jul 10, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·A WagnerD Arveiler
Feb 15, 2002·Australian Health Review : a Publication of the Australian Hospital Association·R Bull
Mar 19, 2002·American Journal of Preventive Medicine·Nancy HumpelEva Leslie
Apr 22, 2003·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Brian E SaelensLawrence D Frank
Sep 2, 2003·American Journal of Public Health·John Pucher, Lewis Dijkstra
Apr 7, 2004·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·M Peden, L Sminkey
May 18, 2004·Journal of Epidemiology·Kazuki FujitaShigeru Hisamichi
Jun 24, 2004·American Journal of Preventive Medicine·Neville OwenJames F Sallis
Jul 3, 2004·BMJ : British Medical Journal·Luis Gabriel Cuervo, Jeffrey K Aronson
Jul 6, 2004·Australian and New Zealand Journal of Public Health·Nathan Harten, Tim Olds
Jul 21, 2004·American Journal of Preventive Medicine·Lawrence D FrankThomas L Schmid

❮ Previous
Next ❯

Citations

Jul 24, 2012·Lancet·Pedro C HallalUNKNOWN Lancet Physical Activity Series Working Group
Sep 22, 2009·The International Journal of Behavioral Nutrition and Physical Activity·Sandar Tin TinShanthi Ameratunga
Jan 31, 2014·The International Journal of Behavioral Nutrition and Physical Activity·Tracy Dearth-WesleyShu Wen Ng
Dec 24, 2015·International Journal of Environmental Research and Public Health·E Owen D WaygoodLaurence Letarte
Aug 19, 2007·Preventive Medicine·Jan GarrardSing Kai Lo
Dec 16, 2005·Australia and New Zealand Health Policy·George Thomson, Nick Wilson
Oct 17, 2012·Asia-Pacific Journal of Public Health·Sharon FrielCharles Surjadi
Dec 8, 2014·Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals·Melissa HensleyJohn Minnery
Nov 2, 2020·Progress in Cardiovascular Diseases·Sisitha JayasingheAndrew P Hills
May 15, 2021·Medicine and Science in Sports and Exercise·Helaine M AlessioJanet R Wojcik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.